In The Press

As the FDA and NIH eschew animal testing, startup raises $40 million

Allison DeAngelis
•
May 29, 2025
Biotech Startups and Venture Capital Reporter
Share on

Discover More Articles

view all posts
Vivodyne raises $40M for human tissue drug testing
Vivodyne to Replace Animal Testing With $40 Million Funding
Advantages and Impact of FDA’s Plan to Phase Out Animal Testing for mAbs and Other Drugs
FDA Wants a Shift Away from Animal Testing
FDA Unveils Plan to Replace Animal Testing with Organoids
Human data before the clinic.
Connect With Us
Applications
San Francisco, USA
© 2024 Vivodyne
Privacy
linkedinlinkedinxx